Vascepa

Gavel with scales of justice in background

Amarin, after stock crash and layoffs, revives patent lawsuit

Amarin is getting a fresh shot to challenge Hikma Pharmaceuticals’ generic version of its fish-oil-derived heart med in the lower courts.

Fraiser Kansteiner Jun 26, 2024 1:01pm

revolving door office

Amarin's CEO resigns, leaving former interim chief to take over

Jun 4, 2024 11:19am

Amarin Vascepa box

Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient

Mar 29, 2024 1:10pm

Layoffs

Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt

Jul 19, 2023 10:45am

exit sign

After Amarin's clash with Sarissa, CEO Karim Mikhail hits exit

Mar 31, 2023 11:14am

Knockout

With 7 board resignations, Sarissa strengthens control of Amarin

Mar 7, 2023 10:30am